Loading...
Fetching results...
0 items found

The content in the Resource Centre is not accredited.

Results from the phase III study of nadofaregene firadenovec: Safety and efficacy in patients (pts) with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Presenter

Speaker
N. Shore, Myrtle Beach (US)
Event
35th Annual EAU Congress - Virtual (EAU20V)
Date – time - Location
18 July 2020, 08:30 - 09:05, Virtual room 1
Session
Game changing session - Game changing session 2